Investigational Site 112 — Pensacola, Florida

Investigational Site 112 is a clinical research site located in Pensacola, Florida, United States 32504.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site 112 has participated in 1 clinical trials.

Therapeutic areas: Clostridium Difficile Infection.

Sponsors: Sanofi Pasteur, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pensacola

Browse all research sites in Florida · View every site in Pensacola

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site 112?

Investigational Site 112 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site 112 conducted?

Investigational Site 112 has 1 clinical trials on record. Their work covers Clostridium Difficile Infection.

Is Investigational Site 112 accredited by Crixeo Clinical Trials?

Investigational Site 112 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site 112?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.